Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wyeth is now a wholly owned subsidiary of Pfizer
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients.
Sexually active individuals participating in the study must use a medically acceptable form of contraception during the study and for at least 15 days after the last dose of test article
Subjects must have a primary diagnosis of major depressive disorder
You may not be if
Treatment with DVS-233 SR at any time in the past
Treatment with venlafaxine (immediate release \[IR\] or ER) within 90 days of study day 1
Known hypersensitivity to venlafaxine (IR or ER)
Clareo Health | Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
